ATE80296T1 - Antineoplastische formulierungen. - Google Patents

Antineoplastische formulierungen.

Info

Publication number
ATE80296T1
ATE80296T1 AT89302599T AT89302599T ATE80296T1 AT E80296 T1 ATE80296 T1 AT E80296T1 AT 89302599 T AT89302599 T AT 89302599T AT 89302599 T AT89302599 T AT 89302599T AT E80296 T1 ATE80296 T1 AT E80296T1
Authority
AT
Austria
Prior art keywords
carboplatin
solution
lyophilisate
reconstituting
antineoplastic
Prior art date
Application number
AT89302599T
Other languages
English (en)
Inventor
Harold Phillip Levius
Yisrael Geffen
Benjamin Sklarz
Original Assignee
Abic Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abic Ltd filed Critical Abic Ltd
Application granted granted Critical
Publication of ATE80296T1 publication Critical patent/ATE80296T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/28Compounds containing heavy metals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT89302599T 1988-03-20 1989-03-16 Antineoplastische formulierungen. ATE80296T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL85790A IL85790A0 (en) 1988-03-20 1988-03-20 Solution of carboplatin
EP89302599A EP0334551B1 (de) 1988-03-20 1989-03-16 Antineoplastische Formulierungen

Publications (1)

Publication Number Publication Date
ATE80296T1 true ATE80296T1 (de) 1992-09-15

Family

ID=11058683

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89302599T ATE80296T1 (de) 1988-03-20 1989-03-16 Antineoplastische formulierungen.

Country Status (7)

Country Link
EP (1) EP0334551B1 (de)
AT (1) ATE80296T1 (de)
AU (1) AU623632B2 (de)
DE (1) DE68902755T2 (de)
ES (1) ES2044091T3 (de)
IL (1) IL85790A0 (de)
ZA (1) ZA891360B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5455270A (en) * 1993-08-11 1995-10-03 Bristol-Myers Squibb Co. Stabilized solutions of platinum(II) antitumor agents
EP0743854B1 (de) * 1994-02-07 2001-06-27 PLIVA, pharmaceutical industry incorporated Antitumormittel auf basis von carboplatin und herstellung desselben
CN112638363B (zh) * 2018-08-31 2025-01-24 太阳医药工业有限公司 卡铂的肠胃外剂型
US12427104B1 (en) 2025-04-01 2025-09-30 Ingenus Pharmaceuticals, Llc Injectable carboplatin formulations

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE445172B (sv) * 1978-05-30 1986-06-09 Bristol Myers Co Stabil, steril vattenlosning av cisplatin i enhetsdoseringsform
US4571335A (en) * 1983-06-17 1986-02-18 Taylor Robert C Method of inhibiting herpetic lesions by the use of platinum coordination compounds

Also Published As

Publication number Publication date
AU623632B2 (en) 1992-05-21
DE68902755T2 (de) 1993-01-14
IL85790A0 (en) 1988-09-30
EP0334551A1 (de) 1989-09-27
AU3026589A (en) 1989-09-21
ES2044091T3 (es) 1994-01-01
EP0334551B1 (de) 1992-09-09
DE68902755D1 (de) 1992-10-15
ZA891360B (en) 1989-12-27

Similar Documents

Publication Publication Date Title
GR3004199T3 (de)
DE58906847D1 (de) Stabilisierte wässrige Lösungen von 3-Isothiazolinonen.
NO894740D0 (no) Oftalmisk loesning, samt fremgangsmaate for konservering aven slik loesning.
ATE355850T1 (de) Lyophilisierte hgf-zubereitungen
GR930100416A (el) Στα?εροποιημένο σορβικό οξύ ή άλας αυτού.
DK0666739T3 (da) Intravenøs opløsning som formindsker protein- og vandtab fra kroppen
ATE80296T1 (de) Antineoplastische formulierungen.
ATE65401T1 (de) Stabile, injizierbare loesungen von salzen von vincristin.
ATE92715T1 (de) Feste jodophorzusammensetzung.
SE8704849D0 (sv) Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
NO870941L (no) Vandige preparater med fytotoksisk virkning.
DE59005355D1 (de) Dialysier- und Spüllösung zur intraperitonealen Verarbreichung.
ES2024503B3 (es) Mejoras en, o relacionadas con, el reforzamiento del terreno.
SE8703512D0 (sv) Medel for tandbehandling
DE68902223D1 (de) Waesserige loesungen von doxorubicin.
TH5472A (th) การเตรียมเพพไทด์
FR2269932A1 (en) Synergistic hypotensive compsns for oral admin - contg reserpine and guancydine
NO862740D0 (no) Fremgangsmaate for stabilisering av xantangummi i vandig loesning.
DK540087A (da) Peptidpraeparat

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee